Naproxen Sodium NDC 71205-479

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-479Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0479Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-479-15	71205047915	15 TABLET, FILM COATED in 1 BOTTLE (71205-479-15)Marketed from Sep 30, 2020
71205-479-30	71205047930	30 TABLET, FILM COATED in 1 BOTTLE (71205-479-30)Marketed from Sep 30, 2020
71205-479-60	71205047960	60 TABLET, FILM COATED in 1 BOTTLE (71205-479-60)Marketed from Sep 30, 2020
71205-479-90	71205047990	90 TABLET, FILM COATED in 1 BOTTLE (71205-479-90)Marketed from Sep 30, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naproxen Sodium
Generic name (nonproprietary): naproxen sodium
Active ingredients: Naproxen sodium — 550 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200629
Marketing start: Oct 31, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 71205-479_397db794-027c-4a89-993e-07c208b457a3SPL ID 397db794-027c-4a89-993e-07c208b457a3SPL set ID 397db794-027c-4a89-993e-07c208b457a3RxCUI 849431UNII 9TN87S3A3C
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205047915 followed by a unit qualifier and the quantity

Package 71205-0479-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 1, 2020. This label includes a boxed warning.

Indications (excerpt from the label)

Naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • Polyarticular Juvenile Idiopathic Arthritis • tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea Naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • polyarticular juvenile idiopathic arthritis • tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 200629

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200629
Product	Strength	Form · route	Labeler	Product NDC
Naproxen Sodium	Naproxen sodium 550 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-0822
Naproxen Sodium	Naproxen sodium 275 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1925
Naproxen Sodium	Naproxen sodium 275 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-515
Naproxen Sodium	Naproxen sodium 550 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	65862-516